Aleksandra Petrovic, MD

Aleksandra Petrovic, MD

Immunology, Non-Malignant Transplant Program, Pediatric Blood and Marrow Transplant Program

On staff since November 2016

Children's Title: Attending Physician, Cancer and Blood Disorders Center

Academic Title: Associate Professor, Department of Pediatrics, University of Washington School of Medicine

Research Center: Center for Immunity and Immunotherapies

"There’s nothing more rewarding than following children and their families in the long term. Seeing my patients five or 10 years after their bone marrow transplant — and hearing about all they have accomplished — always puts a smile on my face. "

  • Biography

    Dr. Aleksandra Petrovic specializes in bone marrow transplantation for children with non-malignant conditions, such as bone marrow failure disorders or metabolic disorders.

    While a bone marrow transplant is a lifesaving therapy, it can be very disruptive to daily life. Dr. Petrovic guides each patient and family through this process, discussing the potential risks and benefits, sharing what to expect, working through complications that arise and providing support through the highs and lows.

    Dr. Petrovic also is a physician at Fred Hutchinson Cancer Center and an associate professor in the Department of Pediatrics at the University of Washington School of Medicine. 


  • Patient Testimonials

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    SEATTLE TOP DOCTOR - 2022 Seattle Magazine 2022
  • Publications

    Other Publications

    • Leiding JW, Okada S, Hagin D, Abinun M, Shcherbina A, Balashov DN, Kim VHD, Ovadia A, Guthery SL, Pulsipher M, Lilic D, Devlin LA, Christie S, Depner M, Fuchs S, van Royen-Kerkhof A, Lindemans C, Petrovic A, Sullivan KE, Bunin N, Kilic SS, Arpaci F, Calle-Martin O, Martinez-Martinez L, Aldave JC, Kobayashi M, Ohkawa T, Imai K, Iguchi A, Roifman CM, Gennery AR, Slatter M, Ochs HD, Morio T, Torgerson TR, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium.
      Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations.
      28601685 The Journal of allergy and clinical immunology, 2017 Jun 7
    • Petrovic A, Kostanjsek R, Rakhely G, Knezevic P
      The First Siphoviridae Family Bacteriophages Infecting Bordetella bronchiseptica Isolated from Environment.
      27628741 Microbial ecology, 2017 Feb. : 73(2)368-377
    • Potkonjak A, Kleinerman G, Gutiérrez R, Savić S, Vračar V, Nachum-Biala Y, JuriÅ¡ić A, Rojas A, Petrović A, Ivanović I, Harrus S, Baneth G
      Occurrence of Borrelia burgdorferi Sensu Lato in Ixodes ricinus Ticks with First Identification of Borrelia miyamotoi in Vojvodina, Serbia.
      27574731 Vector borne and zoonotic diseases (Larchmont, N.Y.), 2016 Oct. : 16(10)631-5
    • Al-Jamal RT, Cassoux N, Desjardins L, Damato B, Konstantinidis L, Coupland SE, Heimann H, Petrovic A, Zografos L, Schalenbourg A, Velazquez-Martin JP, Krema H, Bogdali A, Markiewicz A, Romanowska-Dixon B, Metz CH, Biewald E, Bornfeld N, Kiratli H, Bronkhorst IH, Jager MJ, Marinkovic M, Fili M, Seregard S, Frenkel S, Pe'er J, Salvi SM, Rennie IG, Rospond-Kubiak I, Kociecki J, Kiilgaard JF, Heegaard S, Cohen VM, Sagoo MS, Amiryan A, Saakyan S, Eide N, Krohn J, Midena E, Parrozzani R, Grange JD, Kilic E, Blasi MA, Saornil MA, Kivelä TT
      The Pediatric Choroidal and Ciliary Body Melanoma Study: A Survey by the European Ophthalmic Oncology Group.
      26854035 Ophthalmology, 2016 April : 123(4)898-907
    • Knezevic P, Aleksic V, Simin N, Svircev E, Petrovic A, Mimica-Dukic N
      Antimicrobial activity of Eucalyptus camaldulensis essential oils and their interactions with conventional antimicrobial agents against multi-drug resistant Acinetobacter baumannii.
      26671210 Journal of ethnopharmacology, 2016 Feb 3 : 178125-36
    • Potkonjak A, Gutiérrez R, Savić S, Vračar V, Nachum-Biala Y, JuriÅ¡ić A, Kleinerman G, Rojas A, Petrović A, Baneth G, Harrus S
      Molecular detection of emerging tick-borne pathogens in Vojvodina, Serbia.
      26565929 Ticks and tick-borne diseases, 2016 Feb. : 7(1)199-203
    • Richter A, Petrovic A, Diekhof EK, Trost S, Wolter S, Gruber O
      Hyperresponsivity and impaired prefrontal control of the mesolimbic reward system in schizophrenia.
      26522867 Journal of psychiatric research, 2015 Dec. : 718-15
    • Golusin Z, Jovanović M, Magda N, Stojanović S, Matić M, Petrović A
      Effects of Rusanda Spa balneotherapy combined with calcipotriol on plaque psoriasis.
      26731976 Vojnosanitetski pregled, 2015 Nov. : 72(11)1010-7
    • Petrovic A, Obéric A, Moulin A, Hamedani M
      Ocular adnexal (orbital) solitary fibrous tumor: nuclear STAT6 expression and literature review.
      25761539 Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015 Sept. : 253(9)1609-17
    • Leiding JW, Sriaroon P, Ly JM, Petrovic A, Howard DL, Shamblott M, Kuehn HS, Fleisher TA
      Hypomorphic interleukin-7 receptor α-chain mutations and T-cell deficiency: a delay in diagnosis.
      26123418 Annals of allergy, asthma and immunology : official publication of the American College of Allergy, Asthma, and Immunology, 2015 July : 115(1)1-3
    • Petrovič A, Simonič M
      Effect of Chlorella sorokiniana on the biological denitrification of drinking water.
      25348363 Environmental science and pollution research international, 2015 April : 22(7)5171-83
    • Horn B, Petrovic A, Wahlstrom J, Dvorak CC, Kong D, Hwang J, Expose-Spencer J, Gates M, Cowan MJ
      Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies.
      25644958 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015 April : 21(4)729-37
    • Wagner JE Jr, Eapen M, Carter S, Wang Y, Schultz KR, Wall DA, Bunin N, Delaney C, Haut P, Margolis D, Peres E, Verneris MR, Walters M, Horowitz MM, Kurtzberg J, Blood and Marrow Transplant Clinical Trials Network.
      One-unit versus two-unit cord-blood transplantation for hematologic cancers.
      25354103 The New England journal of medicine, 2014 Oct 30 : 371(18)1685-94 PMCID:PMC4257059
    • Mantel I, Schalenbourg A, Bergin C, Petrovic A, Weber DC, Zografos L
      Prophylactic use of bevacizumab to avoid anterior segment neovascularization following proton therapy for uveal melanoma.
      25034116 American journal of ophthalmology, 2014 Oct. : 158(4)693-701.e2
    • Petrovic A, Bergin C, Schalenbourg A, Goitein G, Zografos L
      Proton therapy for uveal melanoma in 43 juvenile patients: long-term results.
      24405742 Ophthalmology, 2014 April : 121(4)898-904
    • Parikh SH, Mendizabal A, Benjamin CL, Komanduri KV, Antony J, Petrovic A, Hale G, Driscoll TA, Martin PL, Page KM, Flickinger K, Moffet J, Niedzwiecki D, Kurtzberg J, Szabolcs P
      A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.
      24296492 Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014 March : 20(3)326-36 PMCID:PMC3947864
    • Janković SM, Aleksić D, Bahtijari Z, Jelić A, Klacar J, Kovacević A, Mijailović N, Milovanović O, Petrović A, Radovanović A, Sovrlić M, Zecević DR
      Risk factors for severe dental anxiety among medical students.
      24516985 Vojnosanitetski pregled, 2014 Jan. : 71(1)16-21
    • Trotter JR, Sriaroon P, Berman D, Petrovic A, Leiding JW
      Sporothrix schenckii lymphadentitis in a male with X-linked chronic granulomatous disease.
      24241583 Journal of clinical immunology, 2014 Jan. : 34(1)49-52
    • Petrovic AA, Petricevic SM, Ristic SM, Ibric SR, Simic SS, Djuric ZR, Popovic RB
      Preliminary evaluation of the in vitro release and in vivo absorption in rabbits of the modified-release dosage forms.
      22905673 Drug development and industrial pharmacy, 2013 June : 39(6)889-900
    • Duncan CN, Lehmann LE, Cheifetz IM, Greathouse K, Haight AE, Hall MW, Herschberger A, Hill KS, Moffet JR, Morrison RR, Norris AL, Petrovic A, Spear DA, Steiner ME, Talano JA, Tamburro RF, Wagner J, McArthur J, Pediatric Acute Lung Injury and Sepsis (PALISI) Network.
      Clinical outcomes of children receiving intensive cardiopulmonary support during hematopoietic stem cell transplant.
      23392372 Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2013 March : 14(3)261-7
    • Petrovic A, Hale G
      Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies.
      21787195 Expert review of clinical immunology, 2011 July : 7(4)515-25; quiz 526-7
    • Jurisic AD, Petrovic AP, Rajkovic DV, Nicin SDj
      The application of lambda-cyhalothrin in tick control.
      20309723 Experimental and applied acarology, 2010 Sept. : 52(1)101-9
    • Ivić B, Ibrić S, Cvetković N, Petrović A, Trajković S, Djurić Z
      Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G.
      20606343 Chemical and pharmaceutical bulletin, 2010 July : 58(7)947-9
    • Petrovic A, Cvetkovic N, Ibric S, Trajkovic S, Djuric Z, Popadic D, Popovic R
      Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
      20162406 Archives of pharmacal research, 2009 Dec. : 32(12)1767-74
    • Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB
      Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.
      19767509 Blood, 2009 Nov 26 : 114(23)4777-83 PMCID:PMC2786288
    • Petrovic A, Ibric S, Trajkovic S, Popovic R, Djuric Z, Popadic D
      An investigation into effects of in vitro test condition on the release properties of theophylline from HPMC matrices using factorial design.
      19641891 Archives of pharmacal research, 2009 July : 32(7)1087-96
    • Jovanović M, Boza P, Karadaglić D, Brkić S, Petrović A, Mimica-Dukić N, Anackov G, Poljacki M
      Contact sensitivity in patients with psoriasis in Vojvodina.
      19001791 International archives of allergy and immunology, 2009 : 148(4)311-20
    • Markićević M, Petrović A, Kanjer K, Nesković-Konstantinović Z, Nikolić-Vukosavujević D
      Estrogen-regulated cut-off values of pS2 and cathepsin D expression in breast carcinomas.
      18497057 Advances in experimental medicine and biology, 2008 : 617341-8
    • Poljacki M, Jovanović M, Boza P, Mimica-Dukić N, Petrović A, Novović Z
      [Is Vojvodina a risk area for contact weed allergies?].
      16526208 Medicinski pregled, 2005 March : 58(3-4)123-6
    • Sugerman PB, Faber SB, Willis LM, Petrovic A, Murphy GF, Pappo J, Silberstein D, van den Brink MR
      Kinetics of gene expression in murine cutaneous graft-versus-host disease.
      15161652 The American journal of pathology, 2004 June : 164(6)2189-202 PMCID:PMC1615752
    • Petrovic A, Alpdogan O, Willis LM, Eng JM, Greenberg AS, Kappel BJ, Liu C, Murphy GJ, Heller G, van den Brink MR
      LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.
      14563643 Blood, 2004 Feb 15 : 103(4)1542-7


Board Certification(s)

Pediatric Hematology-Oncology

Medical/Professional School

Oregon Health & Science University School of Medicine, Portland, OR


Weill Cornell Medical College, New York, NY


Memorial Sloan-Kettering Cancer Center, New York, NY

Clinical Interests

Bone Marrow Failure Disorders


Metabolic Disorders

Primary Immunodeficiencies

Research Description

Dr. Petrovic develops and leads early phase gene therapy clinical trials at Seattle Children’s Research Institute. Her goal is to improve the treatment of primary immunodeficiencies, a group of inherited disorders that compromise the immune system.